Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma

British Journal of Cancer

Volumn 89, Issue 4, 2003, Pages 754-762

  Kamm, Y J L ^a   Peters, G J ^b   Hull, W E ^c   Punt, C J A ^a   Heerschap, A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

5 fluorouracil; 19F magnetic resonance spectroscopy; C26 murine colon carcinoma

Indexed keywords

CARBOGEN; FLUOROURACIL; THYMIDYLATE SYNTHASE; URIDINE PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CARBOGEN BREATHING; CELL TYPE; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; DRUG METABOLISM; DRUG SENSITIVITY; DRUG UPTAKE; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; GROWTH INHIBITION; GROWTH RATE; IN VIVO STUDY; INHIBITION KINETICS; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RNA ANALYSIS; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; TUMOR GROWTH;

ADMINISTRATION, INHALATION; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARBON DIOXIDE; COLONIC NEOPLASMS; FEMALE; FLUORODEOXYURIDYLATE; FLUOROURACIL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; OXYGEN; RNA, NEOPLASM; SURVIVAL RATE; THYMIDYLATE SYNTHASE;

EID: 0042734824     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601162     Document Type: Article

References (46)

1. Benz C, Cadman E (1981) Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Cancer Res 41: 994-999
2. Chu E, Drake JC, Koeller DM, Zinn S, Jamis-Dow CA, Yeh GC, Allegra CJ (1991a) Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines. Mol Pharmacol 39: 136-143
3. Chu E, Voeller D, Casey J, Drake J, Chabner B, Elwood P, Zinn S, Allegra A (1991b) Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci USA 88: 8977-8981
4. Danenberg PV (1977) Thymidylate synthetase-a target enzyme in cancer chemotherapy. Biochirn Biophys Acta 473: 73-92
5. 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study. Ann Oncol 4: 597-602
6. Grem JL (1990) Fluorinated pyrimidines. In Cancer Chemotherapy: Principles and Practice, Chabner BA, Collins JM (eds) pp 180-224. Philadelphia: Pippincott Co
7. Griffiths JR, McIntyre D, Howe FA, McSheehy PMJ, Ojugo ASE, Rodrigues LM, Wadsworth P, Price NM, Lofts F, Nicholson G, Staid K, Noordhuis P, Peters GJ, Stubbs M (2001) Issues of normal tissue toxicity in patient and animal studies: effect of carbogen breathing in rats after 5-fluorouracil treatment. Acta Oncol 40: 609-614
8. Guichard M, Lartigau E, Martin L, Thomas C, Weeger P, Lambin P, Le Ridant AM, Lusinchi A, Wibault P, Luboinski B, Eschwege F (1994) Tumor oxygenation after (1) carbogen and/or perflubron emulsion administration in tumor xenografts; (2) carbogen administration in patients. Artif Cells Blood Substit Immobil Biotechnol 22: 1355-1360
9. 19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine. Magn Reson Med 38: 907-916
10. Howe FA, Robinson SP, Rodrigues LM, Griffiths JR (1999) Flow and oxygenation dependent (flood) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magn Reson Med 17: 1307-1318
11. Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel AJ, van Daal WA (1995) Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. Radiother Oncol 37: 190-198
12. Kamm YJL, Heerschap A, Wagener DJ (2000) Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma. Eur J Cancer 36: 1180-1186
13. Kitchens ME, Forsthoefel AM, Barbour KW, Rafique Z, Spencer HT, Berger FG (1999) Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization. Implications for autoregulation of translation. J Biol Chem 274: 12544-12547
14. 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver. Magn Reson Med, in press
15. 19F NMR spectroscopy. Magn Reson Med 19: 113-123
16. Koziol JA, Maxwell DA, Fukushima M, Colmerauer ME, Pilch YH (1981) A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment. Biometrics 37: 383-390
17. Lemaire LP, McSheehy PMJ, Griffiths JR (1998) Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo. Cancer Chemother Pharmacol 42: 201-209
18. 19F MR spectroscopic measurement of α-fluoro-β-alanine (FBAL) in patients using a fast 2-point method. Proc Int Soc Magn Reson Med 3: 1862
19. 19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy. NMR Biomed 12: 237-248
20. 19F-NMR of tissues ex vivo. Proc Soc Magn Reson Med 10: 610
21. Martin L, Lartigau E, Weeger P, Lambin P, Le Ridant AM, Lusinchi A, Wibault P, Eschwege F, Luboinski B, Guichard M (1993) Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol 27: 123-130
22. McSheehy PMJ, Prior MJW, Griffiths JR (1989) Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo. Br J Cancer 60: 303-309
23. 19F-MR8 study in vivo. Br J Cancer 65: 369-375
24. McSheehy PMJ, Robinson SP, Ojugo ASE, Aboagye EO, Cannell MB, Leach MO, Judson IR, Griffiths JR (1998) Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. Cancer Res 58: 1185-1194
25. 19F-NMR spectroscopy. J Cancer Res Clin Oncol 117: 295-304
26. Peters GJ, Backus HHJ, Freemantle S, van Triest B, Codacci-Pisanelli G, van der Wilt CL, Smid K, Lunec J, Calvert AH, Marsh S, McLeod HL, Bloemena E, Meijer S, Jansen G, Van Groeningen CJ, Pinedo HM (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta 1587: 194-205
27. Peters GJ, Lankelma J, Kok RM, Noordhuis P, van Groeningen CJ, van der Wilt CL, Meyer S, Pinedo HM (1993) Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma. Cancer Chemother Pharmacol 31: 269-276
28. Peters GJ, Laurensse E, Leyva A, Lankelma J, Pinedo HM (1986) Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res 46: 20-28
29. Peters GJ, Noordhuis P, Komissarov A, Holwerda U, Kok M, van Laar JA, van der Wilt CL, van Groeningen CJ, Pinedo HM (1995) Quantification of 5-fluorouracil incorporation into RNA of human and murine tumors as measured with a sensitive gas chromatography-mass spectrometry assay. Anal Biochem 231: 157-163
30. Peters GJ, Noordhuis P, van Kuilenburg ABP, Schornagel JH, Gall H, Turner SL, Swart MS, Voorn D, van Gennip AH, Wanders J, Holwerda U, Smid K, Giaccone G, Fumoleau P, van Groeningen CJ (2003) Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors. Cancer Chemother Pharmacol 52: 1-12
31. Peters GJ, Van Dijk J, Nadal JC, van Groeningen CJ, Lankelma J, Pinedo HM (1987) Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo 1: 113-117
32. 31p-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. Br J Cancer 75: 62-68
33. Sijens PE, Baldwin NI, Ng TC (1991) Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Magn Reson Med 19: 373-385
34. 19F magnetic resonance spectroscopy. Magn Reson Imaging 10: 385-392
35. Schmitz JC, Liu J, Lin X, Chen TM, Yan W, Tai N, Gollerkeri A, Chu E (2001) Translational regulation as a novel mechanism for the development of cellular drug resistance. Cancer Metastasis Rev 20: 33-41
36. 19F NMR. Br J Cancer 50: 113-117
37. 19F-nuclear magnetic resonance spectroscopy study in vivo. Cancer Chemother Pharmacol 37: 259-265
38. 31P MRS: absolute concentrations, signal-to-noise and prior knowledge. NMR Biomed 8: 87-93
39. van der Sanden BPJ, Heerschap A, Hoofd L, Simonetti AW, Nicolay K, van der Toorn A, Colier WNJM, van der Kogel AJ (1999) Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magn Reson Med 42: 490-499
40. van der Wilt CL, Backus HHJ, Smid K, Comijn EM, Veerman G, Wouters D, Voorn DA, Priest DG, Bunni MA, Mitchell F, Jackman AL, Jansen G, Peters GJ (2001) Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. Cancer Res 61: 3675-3681
41. van der Wilt CL, Pinedo HM, Smid K, Peters GJ (1992) Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors. Cancer Res 52: 4922-4928
42. van Laar JA, Rustum YM, van der Wilt CL, Smid K, Kuiper CM, Pinedo HM, Peters GJ (1996a) Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas. Cancer Chemother Pharmacol 39: 79-89
43. van Laar JA, van der Wilt CL, Rustum YM, Noordhuis P, Smid K, Pinedo HM, Peters GJ (1996b) Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model. Clin Cancer Res 2: 1327-1333
44. 18F]-5-fluorouracil in a mouse bearing two colon tumors with a different 5-fluorouracil sensitivity: a study for a correlation with oncological results. Nucl Med Biol 23: 333-342
45. Washtien WL (1984) Comparison of 5-fluorouracil metabolism in two human gastrointestinal tumor cell lines. Cancer Res 44: 909-914
46. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom. Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1-10